Virtual Medicinal Product (VMP) - Tapentadol 50mg modified-release capsules
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Tapentadol 50mg modified-release capsules | Start Date 24-06-2022 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 2 (CD)
- Route
- Oral
- Form
- Modified-release capsule
- Ontology Form/Route
- capsulemodified-release.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- N02AX06
- BNF Codes
-
- BNF code 04070200
| Code | Start Date | End Date |
|---|---|---|
| 40777511000001108 | 24-06-2022 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Tapentadol phosphate | Based on Base Substance | Tapentadol | 50 mg |
Name
Tapentadol phosphate
Basis of strength description
Based on Base Substance
BOSS
Tapentadol
Strength and UOM (Nmr)
50.0
Strength and UOM (Dmr)
Parent Products
-
VTMTapentadol
-
VMP(Current) Tapentadol 50mg modified-release cap...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 28 capsule | 1059 | Part VIIIA Category C |
| 56 capsule | 2117 | Part VIIIA Category C |